Sonoma Pharmaceuticals Statistics
Total Valuation
SNOA has a market cap or net worth of $4.88 million. The enterprise value is $3.12 million.
Important Dates
The next estimated earnings date is Tuesday, June 16, 2026, after market close.
| Earnings Date | Jun 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SNOA has 4.69 million shares outstanding. The number of shares has increased by 60.61% in one year.
| Current Share Class | 4.69M |
| Shares Outstanding | 4.69M |
| Shares Change (YoY) | +60.61% |
| Shares Change (QoQ) | +4.07% |
| Owned by Insiders (%) | 0.43% |
| Owned by Institutions (%) | 2.32% |
| Float | 4.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.28 |
| Forward PS | 0.24 |
| PB Ratio | 0.56 |
| P/TBV Ratio | 1.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.88 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -81.19% and return on invested capital (ROIC) is -38.09%.
| Return on Equity (ROE) | -81.19% |
| Return on Assets (ROA) | -12.67% |
| Return on Invested Capital (ROIC) | -38.09% |
| Return on Capital Employed (ROCE) | -29.41% |
| Weighted Average Cost of Capital (WACC) | 12.34% |
| Revenue Per Employee | $2.22M |
| Profits Per Employee | -$421,250 |
| Employee Count | 8 |
| Asset Turnover | 1.30 |
| Inventory Turnover | 3.20 |
Taxes
| Income Tax | -80,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.41% in the last 52 weeks. The beta is 1.76, so SNOA's price volatility has been higher than the market average.
| Beta (5Y) | 1.76 |
| 52-Week Price Change | -75.41% |
| 50-Day Moving Average | 2.38 |
| 200-Day Moving Average | 3.40 |
| Relative Strength Index (RSI) | 25.68 |
| Average Volume (20 Days) | 393,721 |
Short Selling Information
The latest short interest is 16,112, so 0.34% of the outstanding shares have been sold short.
| Short Interest | 16,112 |
| Short Previous Month | 38,967 |
| Short % of Shares Out | 0.34% |
| Short % of Float | 0.34% |
| Short Ratio (days to cover) | 0.42 |
Income Statement
In the last 12 months, SNOA had revenue of $17.72 million and -$3.37 million in losses. Loss per share was -$2.04.
| Revenue | 17.72M |
| Gross Profit | 6.76M |
| Operating Income | -2.77M |
| Pretax Income | -3.45M |
| Net Income | -3.37M |
| EBITDA | -2.63M |
| EBIT | -2.77M |
| Loss Per Share | -$2.04 |
Full Income StatementBalance Sheet
The company has $2.56 million in cash and $655,000 in debt, giving a net cash position of $1.91 million or $0.41 per share.
| Cash & Cash Equivalents | 2.56M |
| Total Debt | 655,000 |
| Net Cash | 1.91M |
| Net Cash Per Share | $0.41 |
| Equity (Book Value) | 3.43M |
| Book Value Per Share | 1.98 |
| Working Capital | 7.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.51 million and capital expenditures -$210,000, giving a free cash flow of -$3.72 million.
| Operating Cash Flow | -3.51M |
| Capital Expenditures | -210,000 |
| Depreciation & Amortization | 137,000 |
| Net Borrowing | -27,000 |
| Free Cash Flow | -3.72M |
| FCF Per Share | -$0.79 |
Full Cash Flow StatementMargins
Gross margin is 38.16%, with operating and profit margins of -15.61% and -19.02%.
| Gross Margin | 38.16% |
| Operating Margin | -15.61% |
| Pretax Margin | -19.47% |
| Profit Margin | -19.02% |
| EBITDA Margin | -14.83% |
| EBIT Margin | -15.61% |
| FCF Margin | n/a |